Google
Trusted Resources: News & Events
Latest announcements and gatherings
MARAC Advisory Statement: Monoclonal Antibodies Against SARS-CoV-2
August 26, 2021 – The Sickle Cell Disease Association of America Medical and Research Advisory Committee has released a statement with updated COVID-19 guidance.
MARAC recommends that people with sickle cell disease should have access to monoclonal antibody (mAbs) treatment according to established guidelines, to prevent mild COVID from progressing to severe disease.
Read the full recommendations for providers, policy makers and patients.
+myBinderRelated Content
-
Healthcare advocates aim to better inform community on sickle cell realitiesOne in 2,400 are born with sickle cell d...
-
Today’s Faces of Sickle Cell Disease: Kirti DasuKirti Dasu was born in South East India ...
-
Sickle Cell Disease Association of America Philadelphia/Delaware Valley ChapterThe Sickle Cell Disease Association of A...
-
Dexter DardenDexter Darden is an American actor. He i...
-
Rare Disease Day at NIH 2023Rare Disease Day® takes place worldwide...
-
Fredericksburg Area Sickle Cell AssociationThe Fredericksburg Area Sickle Cell Asso...
-
Eileen MurrayEileen Murray is currently working as Ce...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
SomeBodyToTalkTo connects people affected by rare diseases with trusted resources, supportive communities, and opportunities to share their experiences.